Lysophosphatidylcholine a C17:0
lipidLysophosphatidylcholine a C17:0 is an oxidized lipid product characteristic of acute coronary syndrome metabolomic profiles.
Pathway placement
Cascade stepLipid retention & oxidation
Confidencemedium
RationaleOxidized phospholipid; ACS metabolomic signature; plaque lipid remodeling.
Also acts inVascular inflammation, Systemic / off-pathway
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma (EDTA to limit oxidation)
Collection tube
K2/K3-EDTA (lavender-top) · Serum separator (gold/red-top, SST)
Method / principle
LC-MS/MS lipidomics (targeted or shotgun)
Reagent / substrate
Deuterated lipid-class internal standards; MS/MS transitions
Platform
LC-MS/MS
Turnaround · availability
Research · Research-only
Literature evidence(2)
- Plasma metabolomic profiling of patients with acute coronary syndrome treated with potent platelet inhibitors.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026 · PMID 41564597 · doi
- The Serum Metabolic Biomarkers in Early Diagnosis and Risk Stratification of Acute Coronary Syndrome.Frontiers in physiology · 2020 · PMID 32792969 · doi